April 26, 2017

PA Waiver Training Module

Jeffrey DeVido M.D., M.T.S., Shelly F. Greenfield M.D., M.P.H.

Begin Course

Educational Objectives:

  • Discuss the epidemiology of substance use disorders (opioid use disorders in particular) in pregnant women
  • Describe both the maternal and fetal/infant risks of opioid use disorders in pregnancy
  • Discuss the range of screening approaches to opioid use disorders in pregnancy
  • State mandatory reporting issues
  • List the various medication-assisted-treatment (MAT) options for opioid dependent pregnant women including: Naltrexone, Methadone, and buprenorphine
  • Discuss behavioral treatment options for management of opioid use disorders in pregnant women